Your browser doesn't support javascript.
loading
COVID-19 vaccine coverage, safety, and perceptions among patients with diabetes mellitus in China: a cross-sectional study.
Li, Haolong; Ping, Fan; Li, Xiaomeng; Wang, Zhihong; Xiao, Jianzhong; Jiang, Hongwei; Xue, Yaoming; Quan, Jinxing; Yao, Hebin; Zheng, Xianling; Chen, Yanming; Li, Yufeng; Yu, Xiaohua; Xu, Lingling; Feng, Xinxin; Wang, Siyu; Li, Yongzhe; Xiao, Xinhua.
Affiliation
  • Li H; Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Ping F; Department of Endocrinology, Peking Union Medical College Hospital, Beijing, China.
  • Li X; Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Wang Z; Department of Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Xiao J; Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Jiang H; Department of Endocrinology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
  • Xue Y; The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
  • Quan J; Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Yao H; Department of Endocrinology, Gansu Provincial People's Hospital, Lanzhou, Gansu, China.
  • Zheng X; Department of Endocrinology, Sixth Medical Center of PLA General Hospital, Beijing, China.
  • Chen Y; Department of Endocrinology, Handan Central Hospital, Handan, China.
  • Li Y; Department of Endocrinology & Metabolism, Guangdong Provincial Key Laboratory of Diabetology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Yu X; Department of Endocrinology, Capital Medical University, Beijing, China.
  • Xu L; Department of Endocrinology, Liaoyang Central Hospital, Liaoyang, Liaoning, China.
  • Feng X; Department of Endocrinology, ShenZhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
  • Wang S; Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Li Y; Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Xiao X; Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Front Endocrinol (Lausanne) ; 14: 1172089, 2023.
Article in En | MEDLINE | ID: mdl-37334292
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Diabetic Nephropathies / Drug-Related Side Effects and Adverse Reactions / COVID-19 Vaccines / COVID-19 Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Diabetic Nephropathies / Drug-Related Side Effects and Adverse Reactions / COVID-19 Vaccines / COVID-19 Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country: Country of publication: